MBD2 and breast carcinoma: To identify differentially methylated regions (DMRs) in TNBCs, the DNA of breast tumors and matched normal samples for each of the four breast cancer subtypes was enriched with methyl-binding domain protein 2 (MBD-2), followed by massive parallel sequencing (MBD-seq).